Email this article Multimodality treatment in patients with operable distal rectal cancer
- Authors: Barsukov Y.A.1, Tkachev S.I.1, Kuzmichev D.V.1, Mamedli Z.Z.1, Pavlova A.M.1
-
Affiliations:
- N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
- Issue: Vol 1, No 3 (2012)
- Pages: 28-37
- Section: ORIGINAL REPORTS
- Published: 28.02.2015
- URL: https://onco-surgery.info/jour/article/view/52
- DOI: https://doi.org/10.17650/2220-3478-2012-0-3-28-37
- ID: 52
Cite item
Full Text
Abstract
More than 30-year experience of the department of proctology of N.N. Blokhin Russian Cancer Research Center, which demonstrates the necessity in developing complex treatment for distal rectal cancer is presented in this article. An original treatment scheme has been developed, incorporating radiotherapy (short course 5 Ч 5 Gy) with 2 radiosensitizers and systemic cytotoxic therapy with fluorpyrimidines (capecitabine). The developed treatment scheme has acceptable toxicity and can be combined with all types of surgical interventions. A significant reduction in local and distant failures rates can be achieved as well an improvement of disease-free survival. This allows to increase indications to sphincter-sparing treatment by improving ablastics of surgery and provide high level of social rehabilitation.
About the authors
Yu. A. Barsukov
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Author for correspondence.
Email: barsukov@oncoproct.ru
Russian Federation
S. I. Tkachev
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: fake@neicon.ru
Russian Federation
D. V. Kuzmichev
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: fake@neicon.ru
Russian Federation
Z. Z. Mamedli
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: fake@neicon.ru
Russian Federation
A. M. Pavlova
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Email: fake@neicon.ru
Russian Federation
References
Supplementary files
